IMAB.us experienced a significant stock drop of 5.69%, with the price reaching $0.990 per share and a trading volume of 135,482 shares. The turnover rate was 0.17%, and the stock showed a volatility of 7.62%. Recent financial reports indicated zero revenue, a net loss of $17.82 million, and earnings per share at -$0.30, resulting in a price-to-earnings ratio of -1.04.
Despite this, both participating institutions rated the stock as a buy. Within the biotechnology sector, which saw an overall increase of 0.18%, other stocks like Psyence Biomedical Ltd and Surrozen Inc showed notable gains and high turnover rates.
